OverviewSuggest Edit
23andMe is a consumer genetics and research company. It helps individuals to understand their own genetic information through DNA analysis technologies and web-based interactive tools. The сompany enables people to gain insights into their ancestry and genetic makeup.
| Type | Private | |
| Founded | 2006 | |
| HQ | Sunnyvale, US | Map |
| Website | 23andme.com | |
| Employee Ratings | More | |
| Culture score | C- | More |
Recent NewsAll News
- The DNA testing industry is stuck in a rut. Here's how 23andMe and Ancestry are plotting their next moves.
- Consumer DNA testing is a bust: Here's how companies like Ancestry and 23andMe can survive
- 23andMe CEO Anne Wojcicki is ‘surprised’ that DNA test sales have declined. I’m not.
- 23andMe Lays Off 14% Of Workforce Amid Declining DNA Test Sales
Key People/Management at 23andMe
Anne Wojcicki
CEO and Co-Founder
Arin Assero
Director of Research Communities & Advocacy
Astrid Ruefli-Brasse
Vice President, Drug Discovery
Jennifer Low
Head of Therapeutics Development
Joyce Tung
Vice President, Research
Jeffrey Pollard
Director of Medical Affairs
23andMe Office Locations
23andMe has an office in Sunnyvale
Sunnyvale, US (HQ)
223 N Mathilda Ave
23andMe Financials and Metrics
Summary Metrics
Founding Date | 2006 |
23andMe total Funding | $830 m |
Time since last funding | a year ago |
23andMe investors | Sequoia Capital, New Enterprise Associates, Google, DST Global, Google Ventures, Fidelity Investments, Mohr Davidow Ventures, Altimeter Capital, Xfund, Genentech, Johnson & Johnson Development Corporation, MPM Capital, National Institutes of Health, Illumina, Casdin Capital, Stephens Investment Management, GV, Anne Wojcicki, Euclidean Capital, Fidelity Management, Sergey Brin, GlaxoSmithKline, Wallenberg Foundations, Raj Luhar, WuXi Venture Fund |
23andMe's latest valuation is reported to be $2.5 b.
23andMe Revenue
23andMe's revenue was reported to be $475 m in Y, 2018
| USD | |
|---|---|
Revenue (Y, 2018) | 475.0m |
Market valuation | 2.5b |
- Source: Sharespost
| USD | Y, 2018 |
|---|---|
Revenue/Employee | 833.9k |
23andMe Acquisitions / Subsidiaries
| Company Name | Date | Deal Size |
|---|---|---|
| CureTogether | July 10, 2012 |
23andMe Online and Social Media Presence
93.04k Twitter followers
23andMe has 93.04k Twitter Followers. The number of followers has decreased 0.1% month over month and decreased 0.3% quarter over quarter
23andMe's Trends
Twitter Engagement Stats for @23andMe
17.7k
Tweets
7.2k
Following
93k
Followers
16
Tweets last 30 days
9.9
Avg. likes per Tweet
100%
Tweets with engagement
23andMe Company Culture
Overall Culture
C-
66/100
CEO Rating
A+
90/100
Compensation
C+
70/100
Diversity
C+
72/100
23andMe News and Updates
February 11, 2020
The DNA testing industry is stuck in a rut. Here's how 23andMe and Ancestry are plotting their next moves.
Two of the biggest consumer genetics companies — 23andMe and Ancestry — have recently laid off workers, citing a slowdown in the market for their tests.
Consumers aren't flocking to send their spit into genetic testing companies in as high a numbers as the industry expected, an issue the industry…
February 09, 2020
Consumer DNA testing is a bust: Here's how companies like Ancestry and 23andMe can survive
CNBC asked genetics experts to weigh in on why the consumer DNA market has stalled. And how 23andMe, Ancestry and others can continue to scale their businesses in light of that.
January 24, 2020
23andMe CEO Anne Wojcicki is ‘surprised’ that DNA test sales have declined. I’m not.
The company had to lay off 100 employees as a result.
January 23, 2020
23andMe Lays Off 14% Of Workforce Amid Declining DNA Test Sales
In an interview with CNBC, CEO Anne Wojcicki said she is “surprised” to see plunging sales.
January 23, 2020
Layoffs reach 23andMe after hitting Mozilla and the Vision Fund portfolio
Layoffs in the technology and venture-backed worlds continued today, as 23andMe confirmed to CNBC that it laid off around 100 people, or about 14% of its formerly 700-person staff. The cuts would be notable by themselves, but given how many other reductions have recently been announced, they indicat…
January 23, 2020
23andMe lays off 100, with CEO “surprised” at market turn
The layoffs impact 14% of the genetic testing company’s staff.
Consumer genetic testing company 23andMe is laying off 100 people (or 14% of its staff) due to declining sales, reports CNBC.Read Full Story
23andMe Blogs
April 08, 2020
Could genetics play a role in the severity of COVID-19?
We know genetics plays a role in the severity and susceptibility of other infectious diseases, but does genetics play a role in the severity of some cases of COVID-19? 23andMe is currently conducting research with the aim of learning more.
The post Could genetics play a role in the severity of CO…
April 06, 2020
23andMe Engages Its Millions of Research Participants to Study COVID-19
23andMe scientists began a study of COVID-19, the disease caused by the coronavirus SARS-CoV-2, to understand how genetics may influence the differences in severity of the disease among people.
The post 23andMe Engages Its Millions of Research Participants to Study COVID-19 appeared first on 23andM…
April 02, 2020
23andMe’s Parkinson’s Research Community, More than a Decade of Discovery
As part of Parkinson's Awareness month, 23andME looks back over the now 11 years since we formed the Parkinson's Research Community and note some of what we've accomplished.
The post 23andMe’s Parkinson’s Research Community, More than a Decade of Discovery appeared first on 23andMe Blog.
March 31, 2020
Researchers find new genetic associations for nearsightedness
A new study found previously unknown genetic mechanisms for myopia, or nearsightedness, including associations with circadian rhythms, as well as skin, eye and hair pigmentation.
The post Researchers find new genetic associations for nearsightedness appeared first on 23andMe Blog.
March 24, 2020
Study Finds Health Impact for Early Puberty in Boys
Early puberty in boys is associated with shorter lifespans, according to a new genetic study by researchers at the University of Cambridge.
The post Study Finds Health Impact for Early Puberty in Boys appeared first on 23andMe Blog.
March 19, 2020
New Genetic Research on Skin Cancer
A large new study led by researchers at the University of Indiana that included data from 23andMe has found new genetic associations for squamous cell skin cancers.
The post New Genetic Research on Skin Cancer appeared first on 23andMe Blog.
23andMe Frequently Asked Questions
When was 23andMe founded?
23andMe was founded in 2006.
Who are 23andMe key executives?
23andMe's key executives are Anne Wojcicki, Arin Assero and Astrid Ruefli-Brasse.
How many employees does 23andMe have?
23andMe has 677 employees.
What is 23andMe revenue?
Latest 23andMe annual revenue is $475 m.
What is 23andMe revenue per employee?
Latest 23andMe revenue per employee is $701.6 k.
Who are 23andMe competitors?
Competitors of 23andMe include Natera, Ambry Genetics and Ancestry.
Where is 23andMe headquarters?
23andMe headquarters is located at 223 N Mathilda Ave, Sunnyvale.
Where are 23andMe offices?
23andMe has an office in Sunnyvale.
How many offices does 23andMe have?
23andMe has 1 office.
Learn about Craft real-time company insights
Receive alerts for 300+ data fields across thousands of companies